Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.02.21.635719

EEG responses to auditory cues predict fluency variability and stuttering intervention outcome

Abstract

Stuttering is a variable speech disorder whose brain mechanisms remain unknown. Sensorimotor brain circuits, critical for motor-speech control, including auditory processing necessary for speech prediction and monitoring, have been linked to the disorder. Despite considerable advances, it remains unclear whether auditory circuits relate to stuttering variability, and whether the panoply of interventions for persons who stutter can lead to brain changes within these circuits. We employed electroencephalography (EEG), in a group of persons who stutter, in combination with auditory probes to tap onto the importance of auditory cortical regions in stuttering variability. Participantsproduced flexible speech (i.e., describing visual scenes) and non-flexible speech (i.e., reading syllables), following an auditory cue. More pronounced P200 auditory evoked potentials were observed in participants with higher dysfluency rates, mainly in the spontaneous speech task. Interestingly, speech therapy intervention led to a reduction of the P200 potential, which was in turn significantly related to fluency improvements. Furthermore, EEG response patterns discriminative of cue frequency (400 or 800 Hz tones) were also predictive of dysfluency scores. Our study highlights the involvement of auditory cortical processing and that of auditory attention in stuttering variability. We support that a higher state of auditory alertness may be implicated in the sensorimotor mechanisms of stuttering, and that speech therapy interventions promoting more self-confident communication can restraint auditory alertness, and potentially reduce speech dysfluencies. HighlightsO_LIAuditory probes can assess the auditory cortex in speech production and stuttering. C_LIO_LIStuttering severity correlates to EEG auditory responses during speech preparation. C_LIO_LIHigher states of auditory alertness in stuttering may be reduced by speech therapy. C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=123 SRC="FIGDIR/small/635719v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@18a639dorg.highwire.dtl.DTLVardef@91efc6org.highwire.dtl.DTLVardef@114dd97org.highwire.dtl.DTLVardef@e01024_HPS_FORMAT_FIGEXP M_FIG C_FIG Speaking requires orchestrating several brain processes at a time. The auditory system assumes a central role, not only in waiting for the right moment to initiate speech, listening to self-produced speech, predicting the consequence of future speech, but also adjusting these processes to the intermittent nature of stuttering.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Rocha, M. F., Carmona, J., Correia, J. M.. 2025-02-24. EEG responses to auditory cues predict fluency variability and stuttering intervention outcome. https://doi.org/10.1101/2025.02.21.635719

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗